# Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

> **NCT06574373** · — · RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 3600 (estimated)

## Conditions studied

- IPMN, Pancreatic

## Interventions

- **OTHER:** Blood Collection Protocol for Patients with Indolent, Invasive, and Pancreatic Cancer-Associated IPMN Based on Clinical Course and Surgical Intervention

## Key facts

- **NCT ID:** NCT06574373
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-29
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 3600 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06574373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06574373, "Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06574373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*